Semaglutide Tablets bulk supplier for pharma manufacturers

Semaglutide Tablets 3 mg, 7 mg, 14 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 3 mg, 7 mg, 14 mg

Pack Sizes: 10 and 30 tablets in blisters

Reference Brands: Rybelsus

Category: Diabetes

Semaglutide tablets are the oral form of the GLP-1 medicine semaglutide, used for type 2 diabetes. PharmaTradz sources them for importers and licensing partners in markets where the semaglutide patent has expired.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Semaglutide Tablets? List it or send an offer →

Product Description:

Semaglutide is a GLP-1 receptor agonist. It acts like the gut hormone GLP-1: it makes the pancreas release insulin when blood sugar is high, lowers glucagon, slows stomach emptying and reduces appetite. Most semaglutide is given as a weekly injection. The tablet is the only oral version, made possible by an absorption enhancer (SNAC) that protects the peptide in the stomach long enough for it to be absorbed.

The tablets are used for adults with type 2 diabetes, usually starting at 3 mg once daily for a month and stepping up to 7 mg and then 14 mg. Absorption is easily disturbed, so the tablet is taken on an empty stomach with a small sip of water (no more than 120 ml), and nothing else is eaten, drunk or taken for at least 30 minutes. Common side effects are nausea, diarrhoea and reduced appetite, mostly in the first weeks.

Sourcing notes. The semaglutide patent expired in India in March 2026 and Indian companies launched generic versions, including oral tablets from May 2026. Canada, Brazil and China are following, while the US and EU remain under patent for several more years. Patent status therefore decides where a generic can be sold, and we confirm it for each destination before quoting. Tablets are moisture sensitive and are supplied in blisters. Dossier, licensing and white-label enquiries are welcome.

Semaglutide Tablets — third party manufacturing & bulk supply

Semaglutide Tablets 3 mg, 7 mg, 14 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Semaglutide Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Semaglutide Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Semaglutide Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Semaglutide Tablets is listed as Tablets in 3 mg, 7 mg, 14 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Semaglutide Tablets is referenced against Rybelsus. Reference brands are shown for identification only and remain the property of their respective trademark owners.